GlaxoSmithKline has become embroiled in a corruption probe concerning some of its Chinese staff, but its first-half numbers helped to soothe market nerves. Lexâs Julia Grindell and Oliver Ralph discuss the UK drugmaker's results and the importance of China to the business.
